New Pneumococcal Vaccine Guidance for Seniors in 2022 Adult Immunization Schedule

New Pneumococcal Vaccine Guidance for Seniors in 2022 Adult Immunization Schedule

Please check with your Medical Director and other MD Providers for guidance specific to your residents.

Seniors and those who are immunocompromised have new guidance regarding the pneumococcal vaccine in the 2022 adult immunization schedule, according to the Annals of Internal Medicine. These changes, recommended by the Advisory Committee on Immunization Practices, pertain to the zoster, pneumococcal and hepatitis B vaccines. The new guidelines also state that COVID-19 vaccines can be co-administered with other vaccines. 

Among the other recommendations, for those 65 and over who have not gotten a pneumococcal conjugate vaccine or who have unknown vaccination histories, it is recommended that they receive 1 PCV15 dose –– or 1 dose of PCV20. Furthermore, if PCV15 is the dose administered, the second dose should be PPSV23. This guidance is now in the “Routine vaccination” section. 

People in the age range of 19 to 64 with applicable underlying medical conditions or other risk factors who have not gotten the pneumococcal conjugate vaccine or who have an unknown vaccination history should receive one dose of PCV15 or 1 dose of PCV20. If the dose received is PCV15, then the following dose should be PPSV23. This updated guidance is listed in the “Special situations” section of the ACIP.

It also is now recommended that everyone ages 19 to 59 years of age receive the hepatitis B vaccine, and adults over age 60 at risk for hepatitis B virus (HBV) infection.

Regarding the zoster vaccine, there has been additional clarification under the pregnancy section. Now, pregnant women are urged to not receive the zoster vaccine until after giving birth. The immunocompromised section bullet was also modified to show the following changes for the zoster vaccine, stating that the vaccine is currently recommended for people ages 19 and up who are either currently immunocompromised or will be in the future due to a disease or therapy.

The CDC, the American College of Physicians, the American Academy of Family Physicians, the American College of Obstetricians and Gynecologists, the American College of Nurse-Midwives, the American Academy of Physician Associates, and the Society for Healthcare Epidemiology of America all have approved the 2022 schedule.

Caroline Szachnowski – McKnight’s

 

Questions?

Contact:

Laura Hofmann, MSN, RN – Director of Clinical and Nursing Facility Regulatory Services
c: 425-231-4804

PrintNews BulletinArchivesCategories

February 24, 2022